title: Prevention of anaphylactoid shock in the rat by the calmodulin antagonist thioridazine.
abstract: Calmodulin antagonists, which block intracellular calcium/calmodulin-dependent processes like exocytosis, inhibit effectively mast cell mediator release in vitro. Our experiments confirm that they are also effective in vivo. Thioridazine (5 mg/kg), a representative of the group, prevents the severe anaphylactoid shock in the rat, induced with compound 48/80, and permits a rapid and complete recovery, with special protection of respiration. Thus, calmodulin antagonists seem to be potential drugs for the management of mast cell-mediated allergic diseases.
authors: Department of Pharmacology, University of Ulm, FRG.
authors: O
authors: O
authors: Grollmuss
authors: E
authors: E
authors: Sanchez-Delgado
authors: H
authors: H
authors: Bader
mesh_terms: D000707:Anaphylaxis / Q000517:prevention & control*; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D002147:Calmodulin / Q000037:antagonists & inhibitors*; D003490:Cyanosis / Q000517:prevention & control; D006339:Heart Rate / Q000187:drug effects; D006940:Hyperemia / Q000517:prevention & control; D051381:Rats; D011919:Rats, Inbred Strains; D012119:Respiration / Q000187:drug effects; D013881:Thioridazine / Q000627:therapeutic use*; D014554:Urination / Q000187:drug effects; D003189:p-Methoxy-N-methylphenethylamine
chemical_list: D002147:Calmodulin; D003189:p-Methoxy-N-methylphenethylamine; D013881:Thioridazine